Introduction to the Sciatic Nerve Compression Animal Model

The sciatic nerve compression animal model is a classic experimental paradigm that uses surgical techniques to impose controlled mechanical compression on the sciatic nerve, thereby mimicking peripheral nerve injury and neuropathic pain. Common methods include suture ligation, clamping, or wrapping the sciatic nerve with silicone tubing, which induces sustained or subchronic compression and impairs nerve conduction. Following model establishment, affected limbs typically exhibit hyperalgesia, enhanced mechanical allodynia, and impaired motor function, accompanied by pathological changes such as axonal degeneration, myelin sheath damage, and inflammatory responses. This model is widely employed in studies of the mechanisms underlying neuropathic pain and in the evaluation of analgesic agents.

Service Advantages of the Aniphe Biolaboratory Sciatic Nerve Compression Animal Model Platform

Aniphe Biolaboratory sciatic nerve compression animal model platform, centered on the ability to establish controllable nerve injury and stably recapitulate a neuropathic pain phenotype, provides a reliable in vivo evaluation system for analgesic drug development and research into the mechanisms of peripheral nerve injury.

	Multiple modeling approaches are well-established. Supports mainstream modeling methods such as sciatic nerve ligation and partial ligation, catering to diverse research needs.
	The extent of injury is highly controllable. By precisely modulating compression intensity, duration, and location, we can establish a graded modeling system for mild, moderate, and severe nerve injuries.
	The model exhibits high reproducibility. Standardized surgical procedures reduce inter‑individual variability and enhance the consistency of pain‑related behavioral outcomes.
	Pathological features closely resemble clinical findings. It can reliably reproduce typical neuropathic pain phenotypes, including mechanical allodynia, hyperalgesia, and motor dysfunction.
	Multidimensional Behavioral Assessment Systematic pain assessment is achieved by integrating mechanical pain threshold, thermal pain threshold, and motor function testing.

Modeling cycle	6–8 weeks
Laboratory animals	Male SD rats or Wistar rats
Positive drug	Common positive controls include gabapentin (a calcium channel modulator), pregabalin, morphine (a μ‑opioid receptor agonist), duloxetine (an SNRI), and nonsteroidal anti-inflammatory drugs such as celecoxib, which are used to validate the model’s sensitivity to analgesic efficacy.
Application areas	Research on the mechanisms of neuropathic pain (including peripheral sensitization, central sensitization, and glial cell activation); screening of novel analgesic agents; validation of ion channels, neuroinflammation, and immune‑modulatory targets; and preclinical evaluation of neural regeneration and repair strategies, as well as nerve‑encapsulation materials.

Construction of an animal model of sciatic nerve compression

In the chronic constriction injury (CCI) model, after anesthetizing the experimental animals, the sciatic nerve is exposed, and multiple loose sutures are placed at intervals around the nerve trunk, subjecting the nerve to a low‑level, sustained compression over an extended period. This induces axonal conduction impairment and an inflammatory response. In contrast, the partial ligation model involves ligating only selected fascicles of the sciatic nerve, thereby preserving some residual nerve conduction and creating an incomplete lesion that more readily elicits stable hyperalgesia and mechanical allodynia.

Both methods can induce a reduction in the pain threshold of the affected limb, abnormal neuronal discharges, and mild impairment of motor function, accompanied by myelin sheath damage, axonal degeneration, and the release of local inflammatory mediators. They are commonly used models for investigating the mechanisms of neuropathic pain and for evaluating analgesic drugs.